Troglitazone (Standard)
Based on 1 Customer Validation
Troglitazone (Standard) is the analytical standard of Troglitazone. This product is intended for research and analytical applications. Troglitazone is an orally active PPARγ agonist, with EC50s of 550 nM and 780 nM for human and murine PPARγ receptor, respectively. Troglitazone has anticancer activity, prevents and inhibits the development of type 2 diabetes.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 97322-87-7
- Fòrmula: C24H27NO5S
- Peso molecular:441.54
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureza y Documentación
-
Help & FAQs
-
HY-50935
TroglitazonePPARγ Agonist -
HY-13956
PioglitazonePPARγ Agonist -
HY-17386
RosiglitazonePPARγ Agonist -
HY-17356
Fenofibrate -
HY-10838
GW 501516PPARδ Agonist -
HY-17386R
Rosiglitazone (Standard)PPARγ Agonist -
HY-14601
Pioglitazone hydrochloridePPARγ Agonist -
HY-16578
GW9662PPARγ Antagonist -
HY-13861
GW7647PPAR Agonist -
HY-16995
Pirinixic acidPPAR Agonist -
HY-17356R
Fenofibrate (Standard) -
HY-B0258
GemfibrozilCytochrome P450 Inhibitor
Product Information
Information
Aplicación
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
No. CAS 97322-87-7
-
Appearance Solid
-
Peso molecular 441.54
-
Fòrmula C24H27NO5S
-
Color White to off-white
-
SMILES
O=C(SC1CC(C=C2)=CC=C2OCC3(C)OC(C(CC3)=C4C)=C(C)C(C)=C4O)NC1=O
-
Synonyms
CS-045 (Standard)
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
[1]. Willson TM, et al. The PPARs: from orphan receptors to drug discovery. J Med Chem. 2000 Feb 24;43(4):527-50. [Content Brief]
[2]. Fujita M, et al. In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer. J Exp Clin Cancer Res. 2017 Jul 3;36(1):91. [Content Brief]
[3]. Nazim UM, et al. PPARγ activation by troglitazone enhances human lung cancer cells to TRAIL-induced apoptosis via autophagy flux. Oncotarget. 2017 Apr 18;8(16):26819-26831. [Content Brief]
[4]. Knowler WC, et al. Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes. 2005 Apr;54(4):1150-6. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Troglitazone (Standard) Related Classifications
HY-50935R Related Classifications
Powered by Bioz